Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DARE | AMGN | BMY | GILD | VRTX |
| Company | Dare Bioscience Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.2974 | 271.26 | 49.03 | 66.56 | 401.24 |
| High | 0.2974 | 271.26 | 49.03 | 66.56 | 401.24 |
| Low | 0.2974 | 271.26 | 49.03 | 66.56 | 401.24 |
| Last | 0.2974 | 271.26 | 49.03 | 66.56 | 401.24 |
| Change | +0.0001 | -2.28 | +0.04 | -0.47 | -3.67 |
| % Change | +0.03% | -0.83% | +0.08% | -0.70% | -0.91% |
| Volume | 964 | 9,637 | 17,382 | 19,543 | 1,686 |
| 20-Day Average Volume | 469,593 | 2,049,832 | 10,457,124 | 6,068,162 | 929,764 |
| Previous Close | 0.2973 | 273.54 | 48.99 | 67.03 | 404.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4311 | 271.46 | 50.38 | 69.04 | 403.31 |
| 20-Day Raw Stochastic | 6.22% | 37.94% | 20.63% | 8.28% | 33.61% |
| 20-Day Relative Strength | 35.98% | 46.57% | 41.96% | 31.50% | 45.15% |
| Weighted Alpha | -66.27 | +10.17 | -25.66 | -21.63 | +16.28 |
| Today's Opinion | 56% Sell | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 56% Sell | 40% Sell | 88% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 24% Buy | 24% Buy | 8% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.20% since 04/17/24 | +2.72% since 04/17/24 | +2.49% since 04/17/24 | -0.55% since 04/17/24 | +2.07% since 04/17/24 |
| Low | 0.2800 on 04/22/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.3187 on 04/23/24 | 274.48 on 04/23/24 | 49.56 on 04/22/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -37.83% since 03/22/24 | -1.78% since 03/22/24 | -5.58% since 03/22/24 | -8.33% since 03/22/24 | -3.47% since 03/22/24 |
| Low | 0.2800 on 04/22/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.5599 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -5.92% since 01/24/24 | -11.21% since 01/24/24 | -2.41% since 01/24/24 | -16.31% since 01/24/24 | -6.16% since 01/24/24 |
| Low | 0.2800 on 04/22/24 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.5899 on 03/01/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -30.68% since 10/24/23 | -1.76% since 10/24/23 | -12.63% since 10/24/23 | -14.83% since 10/24/23 | +8.63% since 10/24/23 |
| Low | 0.2700 on 12/08/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 0.5899 on 03/01/24 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 29,903 | 146,720,288 | 99,290,928 | 83,457,512 | 104,652,640 |
| Shares Outstanding, K | 100,582 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 2,810,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -30,160,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,810,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -5,060,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.16 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 03/28/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 6.55 | 9.96 | 29.76 |